agilon health, inc. (NYSE:AGL) Receives $4.28 Average Price Target from Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been given a consensus recommendation of “Reduce” by the twenty-one brokerages that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, sixteen have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $4.28.

AGL has been the topic of a number of analyst reports. TD Cowen decreased their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Citigroup cut their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research report on Wednesday, November 13th. Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Finally, Sanford C. Bernstein assumed coverage on agilon health in a report on Wednesday, December 11th. They issued a “market perform” rating and a $2.50 price target for the company.

Insider Buying and Selling at agilon health

In related news, Director Diana Mckenzie bought 12,500 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were acquired at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the purchase, the director now owns 51,319 shares in the company, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 90,000 shares of company stock worth $198,100 in the last 90 days. 3.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On agilon health

Several institutional investors and hedge funds have recently made changes to their positions in AGL. Citigroup Inc. boosted its holdings in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares during the period. AQR Capital Management LLC boosted its holdings in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period. Quantbot Technologies LP bought a new stake in shares of agilon health during the 3rd quarter valued at about $1,742,000. Finally, Susquehanna Fundamental Investments LLC raised its stake in agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares during the period.

agilon health Stock Performance

Shares of AGL opened at $1.90 on Wednesday. agilon health has a 12-month low of $1.50 and a 12-month high of $13.28. The stock has a market cap of $782.83 million, a P/E ratio of -2.02 and a beta of 0.51. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a 50-day moving average of $2.18 and a two-hundred day moving average of $4.09.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the prior year, the firm earned ($0.06) earnings per share. As a group, research analysts predict that agilon health will post -0.52 EPS for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.